FEBS Letters · 2014 · 22 citations · 36 references
Life SciencesBiochemistryPharmacologyMembrane BiophysicsProtein BiochemistryProtein FoldingAmyloid FormationEnzyme InhibitionMembrane ProteinsPeptide Drug DiscoveryProtein AggregationProtein Aggregation DisordersAggregationAmyloid Fibril FormationAmyloid FibrilsAmyloid InhibitionAmyloidogenic IntermediatesInhibition Of Amyloid FormationOligomeric Intermediatesα-Helical Intermediates
A variety of peptides and peptide derivatives have been constructed using the "β-sheet core segment" of amyloid proteins as inhibitors of amyloidogenic fibrillation. A novel all-D-amino-acid from hIAPP β-sheet core segment (hIAPP 22-27) is demonstrated to inhibit hIAPP fibril formation efficiently both at the phospholipid membrane and in bulk solution. The inhibitor terminates hIAPP aggregation to the α-helical oligomeric intermediates at the membrane surface, whereas it stops the aggregation at the stage of β-sheet oligomeric intermediates in bulk solution. This is the first evidence that the inhibition mechanism of the inhibitor at membrane surface is significantly different from that in bulk solution.
36
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Alfredo Lorenzo, Bronwyn L. Razzaboni, Gordon C. Weir et al. · Nature · 1994 · 826 citations